Get started
Evolus, Inc. Common StockEvolus, Inc. Common StockEvolus, Inc. Common Stock

Evolus, Inc. Common Stock

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

EOLS chart


Full chart

EOLS upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪777.03 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.81 USD
Net income (FY)
‪−50.42 M‬ USD
Revenue (FY)
‪266.27 M‬ USD
Shares float
‪56.10 M‬
Beta (1Y)
1.58

Employees


Employees (FY)
332
Change (1Y)
+59 +21.61%
Revenue / Employee (1Y)
‪802.03 K‬ USD
Net income / Employee (1Y)
‪−151.87 K‬ USD

About Evolus, Inc. Common Stock


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
David Moatazedi
Website
evolus.com
Headquarters
Newport Beach
Founded
2012
FIGI
BBG005CX4HK8
Evolus, Inc. is a medical aesthetics company, which engages in the provision of medical aesthetic treatments and procedures. It offers products under the brand of Jeuveau. The company was founded by Scott Cannizzaro in November 2012 and is headquartered in Newport Beach, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

EOLS news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as EOLS.

Frequently Asked Questions


The current price of EOLS is 11.39 USD — it has decreased by −6.79% in the past 24 hours. Watch Evolus, Inc. Common Stock stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Evolus, Inc. Common Stock stocks are traded under the ticker EOLS.
EOLS stock has fallen by −8.15% compared to the previous week, the month change is a −19.22% fall, over the last year Evolus, Inc. Common Stock has showed a −14.75% decrease.
We've gathered analysts' opinions on Evolus, Inc. Common Stock future price: according to them, EOLS price has a max estimate of 27.00 USD and a min estimate of 20.00 USD. Watch EOLS chart and read a more detailed Evolus, Inc. Common Stock stock forecast: see what analysts think of Evolus, Inc. Common Stock and suggest that you do with its stocks.
EOLS reached its all-time high on Jun 7, 2018 with the price of 39.50 USD, and its all-time low was 2.85 USD and was reached on Oct 29, 2020. View more price dynamics on EOLS chart.
See other stocks reaching their highest and lowest prices.
EOLS stock is 9.89% volatile and has beta coefficient of 1.58. Track Evolus, Inc. Common Stock stock price on the chart and check out the list of the most volatile stocks — is Evolus, Inc. Common Stock there?
Today Evolus, Inc. Common Stock has the market capitalization of ‪777.03 M‬, it has decreased by −3.22% over the last week.
Yes, you can track Evolus, Inc. Common Stock financials in yearly and quarterly reports right on TradingView.
Evolus, Inc. Common Stock is going to release the next earnings report on May 13, 2025. Keep track of upcoming events with our Earnings Calendar.
EOLS earnings for the last quarter are 0.03 USD per share, whereas the estimation was 0.01 USD resulting in a 301.16% surprise. The estimated earnings for the next quarter are −0.10 USD per share. See more details about Evolus, Inc. Common Stock earnings.
Evolus, Inc. Common Stock revenue for the last quarter amounts to ‪78.95 M‬ USD, despite the estimated figure of ‪79.00 M‬ USD. In the next quarter, revenue is expected to reach ‪74.18 M‬ USD.
EOLS net income for the last quarter is ‪−6.79 M‬ USD, while the quarter before that showed ‪−19.17 M‬ USD of net income which accounts for 64.57% change. Track more Evolus, Inc. Common Stock financial stats to get the full picture.
No, EOLS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 4, 2025, the company has 332 employees. See our rating of the largest employees — is Evolus, Inc. Common Stock on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Evolus, Inc. Common Stock EBITDA is ‪−24.32 M‬ USD, and current EBITDA margin is −7.97%. See more stats in Evolus, Inc. Common Stock financial statements.
Like other stocks, EOLS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Evolus, Inc. Common Stock stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Evolus, Inc. Common Stock technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Evolus, Inc. Common Stock stock shows the sell signal. See more of Evolus, Inc. Common Stock technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.